Replies to post #3368 on Talon Therapeutics Inc (fka TLON)

[Paul Wall]

Better safe than sorry or should I say, better safe than down 30%.

[lovethatgreen]

yeah so not much more to add on the stop loss subject

TLON has 4 trials happening when you include Menadione

In addition to the Phase 3 confirmatory study of Marqibo in front-line adult elderly ALL, Marqibo is being evaluated in an on-going Phase 3 trial in front-line adult elderly aggressive non-Hodgkin's lymphoma conducted by the German High Grade Non-Hodgkin's Lymphoma Study group, and in a Phase 1 trial in pediatric cancers, including ALL, being conducted by the National Cancer Institute . A phase 2 trial of Marqibo in front-line adult ALL to be conducted by the M.D. Anderson Cancer Center is expected to begin enrolling in the third quarter of 2012.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=77240081